Search
Miridesap
go.drugbank.com/drugs/DB13087InvestigationalMiridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.
Synonyms: 1,1'-hexanedioyldi-D-prolineCategories: Heterocyclic Compounds, 1-RingJTK-853
go.drugbank.com/drugs/DB13095InvestigationalJTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.
Categories: Heterocyclic Compounds, 1-RingCT-2584
go.drugbank.com/drugs/DB13098InvestigationalCT-2584 has been used in trials studying the treatment of Prostate Cancer.
Categories: Heterocyclic Compounds, 2-Ring, Phospholipase D, antagonists & inhibitorsMephedrone
go.drugbank.com/drugs/DB13108InvestigationalMephedrone has been investigated in Alcohol-Related Disorders and Amphetamine-Related Disorders.
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2D6 SubstratesDolcanatide
go.drugbank.com/drugs/DB13112InvestigationalDolcanatide has been investigated in Exposure.
Categories: Guanylyl Cyclase C AgonistsTrabodenoson
go.drugbank.com/drugs/DB13122InvestigationalTrabodenoson has been used in trials studying the treatment of Ocular Hypertension (OHT) and Primary Open-Angle Glaucoma (POAG).
Categories: Adenosine A receptor agonists, Heterocyclic Compounds, 2-RingTroxerutin
go.drugbank.com/drugs/DB13124InvestigationalTroxerutin has been used in trials studying the treatment of Chronic Venous Insufficiency.
Mixtures: LACORYL® T SACHET, LACORYL® -T GELCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-RingLusutrombopag
go.drugbank.com/drugs/DB13125ApprovedInvestigationalx 10^9/L were administered lusutrombopag orally [L4166]. … TPOR is a regulatory target site for endogenous thrombopoietin, which acts as a primary cytokine to promote megakaryocyte proliferation and differentiation, and affect other hematopoietic lineages as well
Categories: P-glycoprotein substrates, Heterocyclic Compounds, 1-RingVaregacestat
go.drugbank.com/drugs/DB13126InvestigationalBMS-986115 has been used in trials studying the treatment of Various Advanced Cancer.
Categories: Heterocyclic Compounds, 2-RingOlokizumab
go.drugbank.com/drugs/DB13127Investigational[A241185, A241175] Olokizumab is a humanized anti-IL-6 IgG4κ antibody that directly blocks gp130 binding at IL-6 Site 3.[A241045] … Targeting IL-6 function can be achieved directly, or through interrupting the IL-6 receptor or gp130 receptor axes.